Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single ascending-dose safety and tolerability study of intravenous ulinastatin in healthy volunteers
ChiCTR-TRC-14005176Phase 4Completed
- Sponsor
- Shanghai Xuhui District Central Hospital
- Start
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ulinastatin (2 arms), sponsored by Shanghai Xuhui District Central Hospital. Primary endpoint: Safety and tolerability. Started Sep 2014; status: completed.
02
Drugs
ulinastatin
Beyond the preview
Go deeper on ChiCTR-TRC-14005176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005176.